CKDB-501A

· CKD Bio Corporation

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for CKDB-501A, covering 2023-12-12 to 2023-12-12. Get the full timeline:

Most recent: Clinical Trial Update: Efficacy and Safety of CKDB-501A in Subjects With Moderate-to-severe Glabellar Lines in Phase 3 Trial [Phase 3]